세계의 POC(Point-of-Care) 진단용 중합효소 연쇄 반응(PCR) 시장 규모는 2024년 16억 달러에서 예측 기간 중 CAGR 5.9%로 추이하며, 2029년말에는 21억 달러에 달할 것으로 예측되고 있습니다.
소모품 부문은 2024년 12억 달러에서 CAGR 6.1%로 추이하며, 2029년말에는 16억 달러에 달할 것으로 예측되고 있습니다. 또한 분석기 부문은 2024년 3억 6,010만 달러에서 CAGR 5.3%로 추이하며, 2029년말에는 4억 6,550만 달러에 달할 것으로 예측되고 있습니다.
시장 구분 :
제품 유형별 :
분석 대상별 :
- POC PCR 분석기 :
- 단일 분석 대상
- 복수 분석 대상
- 소모품 :
- 단일 분석 대상
- 복수 분석 대상
용도별 :
세계의 POC(Point-of-Care) 진단용 중합효소 연쇄 반응(PCR) 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회의 분석, 신규 기술 및 기술개발의 동향, 특허 동향, 시장 규모의 추이·예측, 각종 구분·지역별 상세 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.
목차
제1장 주요 요약
제2장 시장 개요
- 중합효소 연쇄 반응(PCR) 기술
- POC(Point-of-Care) PCR 시스템 및 어세이
제3장 시장 역학
- 시장 역학 : 스냅숏
- 시장 촉진요인
- 시장 기회
- 시장 억제요인
- 시장이 해결해야 할 과제
제4장 신규 기술과 개발
- 개요
- 기구 불요 PCR 검사
- 5분간 POC 검사
- 스마트폰 대응 PCR 시스템
- 특허
- 주요 특허
제5장 세계의 PCR POC 진단 시장
- 부문 내역
- 시장 내역 : 제품 유형별
- 시장 내역 : 분석 대상별
- 분석기 : 분석 대상물별
- 소모품 : 분석 대상물별
- 시장 내역 : 용도별
- 감염증
- 성감염증
- 지역적 내역
- 시장 내역 : 지역별
- 북미
- 라틴아메리카
- 유럽
- 아시아태평양
- 기타 지역
제6장 경쟁 정보
- 업계 시나리오
- 기업 점유율
- 기업간의 경쟁 구도
- POC PCR 분석기의 경쟁 구도
- POC PCR 소모품의 경쟁 구도
제7장 POC(Point-of-Care) 진단용 중합효소 연쇄 반응(PCR) 시장에서의 지속가능성 : ESG 관점
- ESG : 서론
- POC PCR 시장의 지속가능성 : ESG 관점
- 주요 ESG상 문제
- ESG 퍼포먼스 분석
- BCC에 의한 결론
제8장 부록
- 조사 방법
- 두자어
- 참고 문헌
- 기업 개요
- ABBOTT
- CREDO DIAGNOSTICS BIOMEDICAL PTE. LTD.
- DANAHER CORP.
- F. HOFFMANN-LA ROCHE LTD.
- QIAGEN
- QUANTUMDX GROUP LTD.
- THERMO FISHER SCIENTIFIC INC.
- VISBY MEDICAL INC.
KSA
The global market for polymerase chain reaction for point-of-care diagnostics is expected to grow from $1.6 billion in 2024 to $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029.
The global market for PCR POC consumables is expected to grow from $1.2 billion in 2024 to $1.6 billion by the end of 2029, at a CAGR of 6.1% from 2024 through 2029.
The global market for PCR POC analyzers is expected to grow from $360.1 million in 2024 to $465.5 million by the end of 2029, at a CAGR of 5.3% from 2024 through 2029.
Report Scope
This report provides a comprehensive summary of the polymerase chain reaction (PCR) for point-of-care (POC) diagnostics, along with a detailed competitive landscape and profiles of key market players that include revenue, product portfolios and recent activities. The report analyzes trends and dynamics, including drivers, limitations, challenges, and opportunities. This research study discusses historical, current and potential market size. It will enable market players and new entrants to make informed decisions regarding the production and licensing of goods and services. Organizations, distributors and exporters should find useful information regarding market development and trends. The study segments the market on the basis of product type, such as POC PCR analyzers, consumables, single analyte, multi-analyte and applications. Geographical market analysis is provided for all the major segments. The report offers country-level analysis of markets to provide a better understanding of the major segments.
The market is divided into segments and by application/industry:
By Product type:
- POC PCR analyzers.
- Consumables.
By analyte:
- POC PCR analyzers.
- Single analyte.
- Multi-analyte.
- Consumables.
- Single analyte.
- Multi-analyte.
By Application:
- Infectious diseases.
- Sexually transmitted diseases (STIs).
- Other diseases.
Each area is covered in detail, identifying current products in the market in the base year (2023), measuring the current market size and identifying current and potential market drivers, forecasting for 2029, assessing current and potential competitors, and identifying current competitor market shares for 2023.
Report Includes
- 53 data tables and 29 additional tables
- An overview of the global market for polymerase chain reaction (PCR) for point-of-care (POC) diagnostics, along with an evaluation of each market segment's future commercial potential
- Analysis of global market trends, featuring revenue data for 2021-2023, estimates for 2024, and projected CAGRs through 2029
- Evaluation of the current market size and revenue growth prospects, along with a market share analysis by product, analyte, application and region
- Identification of emerging market opportunities, technology trends and issues, and regulatory frameworks pertaining to PCR technology
- A look at the competitive landscape, including an analysis of the impact of COVID-19 as well as the FDA's contribution to COVID-19 diagnostic testing
- A review of patents and new developments in PCR POC technologies
- Profiles of leading market participants, including Abbott, Danaher (Cepheid), Roche, Thermo-Fisher Scientific and QIAGEN
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Polymerase Chain Reaction Technology
- Point of Care PCR Systems and Assays
Chapter 3 Market Dynamics
- Market Dynamics Snapshot
- Market Drivers
- Market Opportunities
- Market Restraints
- Market Challenges
Chapter 4 Emerging Technologies and Developments
- Overview
- Instrument-Free PCR Tests
- Five-Minute Point-of-Care Testing
- Smartphone Enabled PCR System
- Patents
- Selected Patents
Chapter 5 Global Market for PCR POC Diagnostics
- Segmentation Breakdown
- Market Breakdown by Product Type
- Market Breakdown by Analyte
- PCR POC Analyzers by Analyte
- PCR POC Consumables by Analyte
- Market Breakdown by Application
- Infectious Diseases
- STIs
- Geographic Breakdown
- Market Breakdown by Region
- North America
- Latin America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 6 Competitive Intelligence
- Industry Scenario
- Company Shares
- Competitive Landscape Among Companies
- Competitive Landscape in POC PCR Analyzers
- Competitive Landscape in POC PCR Consumables
Chapter 7 Sustainability in the Market for Polymerase Chain Reaction for Point of Care Diagnostics: An ESG Perspective
- Introduction to ESG
- Sustainability in Polymerase Chain Reaction for Point-of-Care Diagnostic Industry: An ESG Perspective
- Key ESG Issues
- ESG Performance Analysis
- Concluding Remarks from BCC Research
Chapter 8 Appendix
- Research Methodology
- Acronyms
- References
- Company Profiles
- ABBOTT
- CREDO DIAGNOSTICS BIOMEDICAL PTE. LTD.
- DANAHER CORP.
- F. HOFFMANN-LA ROCHE LTD.
- QIAGEN
- QUANTUMDX GROUP LTD.
- THERMO FISHER SCIENTIFIC INC.
- VISBY MEDICAL INC.
